<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02767284</url>
  </required_header>
  <id_info>
    <org_study_id>UCST-01.2014</org_study_id>
    <nct_id>NCT02767284</nct_id>
  </id_info>
  <brief_title>A Comparative Study of Six Methods to Measure Human Contrast Vision</brief_title>
  <official_title>UCST Studie 1 - Jämförande Studie Mellan några Befintliga Och Nyutvecklade Metoder för Att mäta Den Spektrala kontrastkänslighetsfunktionen Hos människa</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uppsala University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Uppsala University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the relative performance of different methods to measure the human
      spectral contrast sensitivity function (CSF).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The human spectral contrast sensitivity function (CSF) is a better way to estimate human
      vision than letter charts commonly used by ophthalmologists, optometrists and opticians.

      The current methods used to measure the CSF are often unreliable, due to high variability
      between measurements. This study will compare four (4) new tests with two (2) currently used
      standard tests. The contrast sensitivity function will be measured using all of the six (6)
      methods three times (3) in each of the two (2) eyes at two (2) occasions. Each subjects CSF
      will be measured 6x3x2x2 = 72 times.

      In addition, for each of the CSF measurements, the time used to measure the CSF and number of
      background variables for the subjects will be recorded.

      After informed consent is obtained, the subjects will undergo a visual examination. If they
      match the inclusion criteria they will be included. At that time or at their earliest
      possible convenience, their CSF will be measured using the six methods and some background
      information will be recorded.

      The follow-up measurement occasion will occur between 4 to 6 weeks (28 to 42 days) after the
      first.

      To facilitate comparison with previous studies, the CSF-measurements (in rel.
      contrast/cycles/degree) will be converted to a log (Base 10 logarithm) scale. The unit will
      thus be log CSF (LCSF) [log[relative contrast]/log[cycles/per degree]].
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Average time (in seconds) used to measure the contrast sensitivity function for one eye for each method</measure>
    <time_frame>At end of data collection (up to 12 months after first subject is included)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Average area under the curve for the log contrast sensitivity function (AULCSF) in one eye for each method</measure>
    <time_frame>At end of data collection (up to 12 months after first subject is included)</time_frame>
    <description>The area-under-curve of the LCSF, calculated from the measured CSF.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sources of variability of the average time used to measure the contrast sensitivity function [seconds squared]</measure>
    <time_frame>At end of data collection (up to 12 months after first subject is included)</time_frame>
    <description>The factors occasion, eye, acuity, measurement order, sex,examiner will used in an ANOVA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sources of variability of the average area under the curve for the log contrast sensitivity function [AULCSF squared]</measure>
    <time_frame>At end of data collection (up to 12 months after first subject is included)</time_frame>
    <description>The factors occasion, eye, acuity, measurement order, sex,examiner will used in an ANOVA</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Methods to Measure Contrast Vision</condition>
  <arm_group>
    <arm_group_label>UCST-V1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The UCST-V1 contrast sensitivity test, used to measure CSF thrice in each eye at two occasions in every treatment sequence (multi-period crossover)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>UCST-V2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The UCST-V2 contrast sensitivity test, used to measure CSF thrice in each eye at two occasions in every treatment sequence (multi-period crossover)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>UCST-V3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The UCST-V3 contrast sensitivity test, used to measure CSF thrice in each eye at two occasions in every treatment sequence (multi-period crossover)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Quick-CSF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Quick-CSF test, used to measure CSF thrice in each eye at two occasions in every treatment sequence (multi-period crossover)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pelli-Robson</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Pelli-Robson contrast sensitivity test, used to measure CSF thrice in each eye at two occasions in every treatment sequence (multi-period crossover)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Optec 6500</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The Optec 6500 contrast sensitivity test, used to measure CSF thrice in each eye at two occasions in every treatment sequence (multi-period crossover)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>UCST-V1</intervention_name>
    <description>A previously developed device, Uppsala Contrast Sensitivity Tester - UCST-V1, that quickly measures the human CSF in one stimulus.</description>
    <arm_group_label>UCST-V1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>UCST-V2</intervention_name>
    <description>A refined version of the UCST-V1 that randomizes frequency order.</description>
    <arm_group_label>UCST-V2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>UCST-V3</intervention_name>
    <description>A version that utilises eye-tracking technology to make the measurements more accurate.</description>
    <arm_group_label>UCST-V3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Quick-CSF (QCSF)</intervention_name>
    <description>A fast contrast sensitivity measurement method using a Bayesian algorithm.</description>
    <arm_group_label>Quick-CSF</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pelli-Robson</intervention_name>
    <description>A standard method developed using a Sloan-letter chart with decreasing contrast.</description>
    <arm_group_label>Pelli-Robson</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optec 6500</intervention_name>
    <description>A standard test using sinusoidal gratings to measure the contrast sensitivity function.</description>
    <arm_group_label>Optec 6500</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Normal best corrected visual acuity: LogMAR = 0

          -  No current or previous eye disease in either eye.

          -  Student at Uppsala University

        Exclusion Criteria:

          -  Previous surgery in any eye

          -  Inability to follow the test procedure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prof. Per Söderberg, M.D PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Uppsala University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lars Malmqvist, M.D</last_name>
    <phone>+46186115135</phone>
    <email>lars.malmqvist@neuro.uu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gunneli Ekberg</last_name>
    <phone>+46186115135</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Uppsala University Hospital</name>
      <address>
        <city>Uppsala</city>
        <zip>75185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2016</study_first_submitted>
  <study_first_submitted_qc>May 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2016</study_first_posted>
  <last_update_submitted>June 27, 2016</last_update_submitted>
  <last_update_submitted_qc>June 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Contrast Sensitivity</keyword>
  <keyword>Diagnostic Techniques, Ophthalmological</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Anonymous or pseudo-anonymous data will be available on request or in a repository.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

